Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guidelines – Multiple Myeloma

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Published in 2021 – Ann Oncol (2021)
Authors: M.A. Dimopoulos, P. Moreau, E. Terpos, M. V. Mateos, S. Zweegman, G. Cook, M. Delforge, R. Hájek, F. Schjesvold, M. Cavo, H. Goldschmidt, T. Facon, H. Einsele, M. Boccadoro, J. San-Miguel, P. Sonneveld & U. Mey on behalf of the EHA Guidelines Committee and ESMO Guidelines Committee

  • These Guidelines were developed by the European Hematology Association (EHA) and ESMO. The two societies nominated authors to write the guidelines as well as reviewers to comment on them.
  • These EHA-ESMO Clinical Practice Guidelines provide key recommendations on the management of multiple myeloma 
  • Key treatment recommendations are provided for both newly diagnosed myeloma patients and patients with relapsed/refractory disease  
  • Recommendations for the treatment of plasma cell leukaemia, solitary plasmacytoma and smouldering myeloma are also provided  
  • Key recommendations for myeloma complications, including bone disease and renal impairment, are included

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings